{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:52:30Z","timestamp":1781632350117,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ejca.2008.12.005","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T09:51:42Z","timestamp":1233309102000},"page":"732-735","source":"Crossref","is-referenced-by-count":73,"title":["Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Salvador","family":"Mart\u00edn-Algarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rubi\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9 L\u00f3pez","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo Alonso","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrate","family":"Plazaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Tanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Paz-Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.ejca.2008.12.005_bib1","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1021\/jo960877+","article-title":"Kahalalides: bioactive peptides from a marine mollusk Elysia rufescens and its algal diet bryopsis sp. (1)","volume":"61","author":"Hamann","year":"1996","journal-title":"J Org Chem"},{"key":"10.1016\/j.ejca.2008.12.005_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-3-540-30880-5_16","article-title":"Kahalalide F and ES285: potent anticancer agents from marine molluscs","volume":"43","author":"Faircloth","year":"2006","journal-title":"Prog Mol Subcell Biol"},{"issue":"16S","key":"10.1016\/j.ejca.2008.12.005_bib3","first-page":"2059","article-title":"Clinical and pharmacokinetic phase I dose-finding study of Kahalalide F (KF) administered as a prolonged infusion in patients with solid tumors","volume":"23","author":"Salazar","year":"2005","journal-title":"J Clin Oncol, ASCO Annual Meeting Proc"},{"issue":"4","key":"10.1016\/j.ejca.2008.12.005_bib4","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/1078-0432.CCR-07-4366","article-title":"Phase I clinical and pharmacokinetic study of Kahalalide F administered weekly as a 1-h infusion to patients with advanced solid tumors","volume":"14","author":"Pardo","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.ejca.2008.12.005_bib5","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.1999.17.9.2971","article-title":"Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology","volume":"17","author":"Gralla","year":"1999","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.ejca.2008.12.005_bib6","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","article-title":"Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines","volume":"18","author":"Ozer","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2008.12.005_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2008.12.005_bib8","unstructured":"National Cancer Institute Common Toxicity Criteria. Version 3.0, August 9, 2006. <http:\/\/ctep.cancer.gov\/forms\/CTCAEv3.pdf>. Accessed 31.03.03."},{"key":"10.1016\/j.ejca.2008.12.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"issue":"Suppl 3","key":"10.1016\/j.ejca.2008.12.005_bib10","article-title":"Erythropoietin receptors on tumor cells: what do they mean?","volume":"13","author":"Fandrey","year":"2008","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ejca.2008.12.005_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1200\/JCO.2007.14.3396","article-title":"Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology\/American Society of Hematology clinical practice guideline update","volume":"26","author":"Rizzo","year":"2008","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.ejca.2008.12.005_bib12","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejca.2008.12.005_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene expression profiling of primary cutaneous melanoma and clinical outcome","volume":"98","author":"Winnepenninckx","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 7","key":"10.1016\/j.ejca.2008.12.005_bib14","first-page":"95","article-title":"A phase I and pharmacokinetic study with Kahalalide F in patients with advanced solid tumors using a continuous weekly one hour intravenous infusion schedule","volume":"38","author":"Ciruelos","year":"2002","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2008.12.005_bib15","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1158\/1078-0432.CCR-04-1534","article-title":"Phase I clinical and pharmacokinetic study of Kahalalide F in patients with advanced androgen refractory prostate cancer","volume":"11","author":"Rademaker-Lakhai","year":"2005","journal-title":"Clin Cancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804908010095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804908010095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T04:53:03Z","timestamp":1545454383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804908010095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0959804908010095"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2008.12.005","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}